SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sigachi Industries - Quaterly Results

30 May 2025 Evaluate
A decent increase of about 35.72% in the sales to Rs. 1135.40 millions was observed for the quarter ended March 2025. The sales figure stood at Rs. 836.55 millions during the year-ago period.The Company to register a -40.51%  fall in the net profit for the quarter ended March 2025.The company reported a degrowth in operating Profit to 204.66 millions from 221.38 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 1135.40 836.55 35.72 4078.33 3175.00 28.45 4078.33 3175.00 28.45
Other Income 17.72 71.66 -75.27 200.77 115.73 73.48 200.77 115.73 73.48
PBIDT 204.66 221.38 -7.55 943.39 708.66 33.12 943.39 708.66 33.12
Interest 28.01 24.25 15.51 106.57 70.20 51.81 106.57 70.20 51.81
PBDT 176.65 197.13 -10.39 836.82 638.46 31.07 836.82 638.46 31.07
Depreciation 39.41 27.23 44.73 129.22 87.09 48.38 129.22 87.09 48.38
PBT 137.24 169.90 -19.22 707.60 551.37 28.33 707.60 551.37 28.33
TAX 67.46 52.60 28.25 230.92 141.23 63.51 230.92 141.23 63.51
Deferred Tax 33.30 16.60 100.60 105.18 32.08 227.87 105.18 32.08 227.87
PAT 69.78 117.30 -40.51 476.68 410.14 16.22 476.68 410.14 16.22
Equity 382.12 328.20 16.43 382.12 328.20 16.43 382.12 328.20 16.43
PBIDTM(%) 18.03 26.46 -31.89 23.13 22.32 3.64 23.13 22.32 3.64

Sigachi Industries Share Price

22.52 -0.83 (-3.55%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×